keyword
https://read.qxmd.com/read/38652829/nanoparticle-retinoic-acid-inducible-gene-i-agonist-for-cancer-immunotherapy
#1
JOURNAL ARTICLE
Lihong Wang-Bishop, Mohamed Wehbe, Lucinda E Pastora, Jinming Yang, Blaise R Kimmel, Kyle M Garland, Kyle W Becker, Carcia S Carson, Eric W Roth, Katherine N Gibson-Corley, David Ulkoski, Venkata Krishnamurthy, Olga Fedorova, Ann Richmond, Anna Marie Pyle, John T Wilson
Pharmacological activation of the retinoic acid-inducible gene I (RIG-I) pathway holds promise for increasing tumor immunogenicity and improving the response to immune checkpoint inhibitors (ICIs). However, the potency and clinical efficacy of 5'-triphosphate RNA (3pRNA) agonists of RIG-I are hindered by multiple pharmacological barriers, including poor pharmacokinetics, nuclease degradation, and inefficient delivery to the cytosol where RIG-I is localized. Here, we address these challenges through the design and evaluation of ionizable lipid nanoparticles (LNPs) for the delivery of 3p-modified stem-loop RNAs (SLRs)...
April 23, 2024: ACS Nano
https://read.qxmd.com/read/38652140/human-airway-and-alveolar-organoids-from-bronchoalveolar-lavage-fluid
#2
JOURNAL ARTICLE
Monica Yun Liu, Belinda Chen, Mehdi Borji, Carolina Garcia de Alba Rivas, Antonella F M Dost, Aaron L Moye, Nusrath Movval Abdulla, Margherita Paschini, Stuart D Rollins, Ruobing Wang, Lynn M Schnapp, Hassan A Khalil, Catherine J Wu, Nirmal S Sharma, Carla F Kim
No abstract text is available yet for this article.
April 23, 2024: American Journal of Respiratory and Critical Care Medicine
https://read.qxmd.com/read/38651850/mycosis-fungoides-with-large-cell-transformation-cd30-and-b-cell-chronic-lymphocytic-leukemia
#3
JOURNAL ARTICLE
Mikela Petković, Ivana Ilić, Ružica Jurakić Tončić, Ivo Radman-Livaja, Romana Čeović
Mycosis fugnoides (MF) is an indolent cutaneous T-cell lymphoma (CTLC) and is the most common of all cutaneous lymphomas. An increased risk for developing a second primary malignancy in patients with CTCL has been described in several studies, with a range from 1.04 to 2.4 (1-4). Caucasian males are at higher risk for MF development. MF is often diagnosed at ages between 55 and 67 years, and second malignancy usually occurs 5 or 6 years after the diagnosis of MF was established (5). The most common second primary malignancies include non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), lung carcinoma, bladder carcinoma, and melanoma...
December 2023: Acta Dermatovenerologica Croatica: ADC
https://read.qxmd.com/read/38651033/the-tumor-immune-microenvironment-is-associated-with-recurrence-in-early-stage-lung-adenocarcinoma
#4
JOURNAL ARTICLE
Hiroaki Kanemura, Toshihide Yokoyama, Ryu Nakajima, Atsushi Nakamura, Hiroaki Kuroda, Yoshitaka Kitamura, Hiroyasu Shoda, Nobuaki Mamesaya, Yoshihiro Miyata, Tatsuro Okamoto, Kyoichi Okishio, Masahide Oki, Yuichi Sakairi, Toyofumi Fengshi Chen-Yoshikawa, Tadashi Aoki, Tatsuo Ohira, Isao Matsumoto, Kiyonobu Ueno, Takuro Miyazaki, Haruhisa Matsuguma, Hideoki Yokouchi, Tomoyuki Otani, Akihiko Ito, Kazuko Sakai, Yasutaka Chiba, Kazuto Nishio, Nobuyuki Yamamoto, Isamu Okamoto, Kazuhiko Nakagawa, Masayuki Takeda
INTRODUCTION: Immune checkpoint inhibitors have recently been approved for the treatment of early-stage NSCLC in the perioperative setting on the basis of phase 3 trials. However, the characteristics of such patients who are susceptible to recurrence after adjuvant chemotherapy or who are likely to benefit from postoperative immunotherapy have remained unclear. METHODS: This biomarker study (WJOG12219LTR) was designed to evaluate cancer stem cell markers (CD44 and CD133), programmed death-ligand 1 (PD-L1) expression on tumor cells, CD8 expression on tumor-infiltrating lymphocytes, and tumor mutation burden in completely resected stage II to IIIA NSCLC with the use of archived DNA and tissue samples from the prospective WJOG4107 trial...
April 2024: JTO clinical and research reports
https://read.qxmd.com/read/38650948/short-chain-fatty-acids-induced-lung-tumor-cell-death-and-increased-peripheral-blood-cd4-t-cells-in-nsclc-and-control-patients-ex-vivo
#5
JOURNAL ARTICLE
Carolin D Thome, Patrick Tausche, Katja Hohenberger, Zuqin Yang, Susanne Krammer, Denis I Trufa, Horia Sirbu, Joachim Schmidt, Susetta Finotto
BACKGROUND: Despite therapy advances, one of the leading causes of cancer deaths still remains lung cancer. To improve current treatments or prevent non-small cell lung cancer (NSCLC), the role of the nutrition in cancer onset and progression needs to be understood in more detail. While in colorectal cancer, the influence of local microbiota derived SCFAs have been well investigated, the influence of SCFA on lung cancer cells via peripheral blood immune system should be investigated more deeply...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38650667/potential-therapeutic-effects-and-nano-based-delivery-systems-of-mesenchymal-stem-cells-and-their-isolated-exosomes-to-alleviate-acute-respiratory-distress-syndrome-caused-by-covid-19
#6
REVIEW
Mohsen Ghiasi, Peyman Kheirandish Zarandi, Abdolreza Dayani, Ali Salimi, Ehsan Shokri
The severe respiratory effects of the coronavirus disease 2019 (COVID-19) pandemic have necessitated the immediate development of novel treatments. The majority of COVID-19-related fatalities are due to acute respiratory distress syndrome (ARDS). Consequently, this virus causes massive and aberrant inflammatory conditions, which must be promptly managed. Severe respiratory disorders, notably ARDS and acute lung injury (ALI), may be treated safely and effectively using cell-based treatments, mostly employing mesenchymal stem cells (MSCs)...
December 2024: Regenerative Therapy
https://read.qxmd.com/read/38646492/clinical-prognostic-significance-of-xeroderma-pigmentosum-group-c-and-ifn%C3%A2-%C3%AE-in-non%C3%A2-small-cell-lung-cancer
#7
JOURNAL ARTICLE
Yongming Wang, Weiyu Wang, Huaijie Wang, Liya Qin, Meijia Zhang, Yong Zhang, Yubing Wang, Changcheng Hao, Meihua Qu, Gongchao Wang
Lung cancer is the most common cancer in the world due to its high incidence and recurrence. Genetic instability is one of the main factors leading to its occurrence, development and poor prognosis. Decreased xeroderma pigmentosum group C (XPC) expression notably enhances the stem cell properties of lung cancer cells and increases their proliferation and migration. Additionally, patients with lung cancer and low XPC expression had a poor prognosis. The purpose of the present study was to analyze the effect of XPC and IFN-γ on the clinical prognosis of patients with non-small cell lung cancer (NSCLC)...
June 2024: Oncology Letters
https://read.qxmd.com/read/38645714/epithelial-stem-cells-and-niches-in-lung-alveolar-regeneration-and-diseases
#8
JOURNAL ARTICLE
Jilei Zhang, Yuru Liu
Alveoli serve as the functional units of the lungs, responsible for the critical task of blood-gas exchange. Comprising type I (AT1) and type II (AT2) cells, the alveolar epithelium is continuously subject to external aggressors like pathogens and airborne particles. As such, preserving lung function requires both the homeostatic renewal and reparative regeneration of this epithelial layer. Dysfunctions in these processes contribute to various lung diseases. Recent research has pinpointed specific cell subgroups that act as potential stem or progenitor cells for the alveolar epithelium during both homeostasis and regeneration...
March 2024: Chin Med J Pulm Crit Care Med
https://read.qxmd.com/read/38645153/role-of-numa1-in%C3%A2-breast-cancer-stem-cells-with-implications-for-combination-therapy-of-pim1-and-autophagy-inhibition-in-triple-negative-breast-cancer
#9
Kanakaraju Manupati, Mingang Hao, Michael Haas, Syn Kok Yeo, Jun-Lin Guan
BACKGROUND: Nuclear mitotic apparatus protein 1 (NuMA1) is a cell cycle protein and upregulated in breast cancer. However, the role of NuMA1 in TNBC and its regulation in heterogenous populations remains elusive. METHODS: We performed CRISPR mediated deletion of NuMA1 in mouse TNBC cells, BF3M. FACS was utilized to isolate BCSCs, and bulk cells based on CD29 and CD61 markers. Cell viability, migration, and invasion ability of BCSCs and bulk cells was evaluated using MTT, wound healing and transwell invasion assays, respectively...
April 1, 2024: Research Square
https://read.qxmd.com/read/38644862/mir-199a-5p-targets-dusp14-to-regulate-cell-proliferation-invasion-and-stemness-in-non-small-cell-lung-cancer
#10
JOURNAL ARTICLE
Ying Zheng, Chaokun Yang, Shaoqiang Xie, Desheng Liu, Hui Wang, Jinxin Liu
BACKGROUND: Non-small cell lung cancer (NSCLC) shows the highest morbidity among malignant tumors worldwide. Despite improvements of diagnosis and treatment, patient prognosis remains unfavorable. Therefore, there is a need to discover a novel treatment strategy for NSCLC. DUSP14 is related to various cancers as the regulatory factor for cellular processes. However, its specific roles in NSCLC and the upstream modulator remain largely unclear. METHODS: DUSP14 expression patterns within the lung cancer patient cohort from TCGA database were analyzed using UALCAN online tool...
April 30, 2024: Heliyon
https://read.qxmd.com/read/38642622/anti-inflammatory-effect-of-anadenanthera-colubrina-var-cebil-griseb-altschul-in-experimental-elastase-induced-pulmonary-emphysema-in-rats
#11
JOURNAL ARTICLE
Vinicius Duarte Pimentel, Boris Timah Acha, Gabriel Felicio Gomes, João Luiz Macedo de Sousa Cardoso, Charllyton Luis Sena da Costa, Nelson Jorge Carvalho Batista, Daniel Dias Rufino Arcanjo, Wellington Dos Santos Alves, Francisco de Assis Oliveira
ETHNOPHARMACOLOGICAL RELEVANCE: Medicinal plants have shown promise in the search for new treatments of pulmonary emphysema. Anadenanthera colubrina, a species native to the Caatinga biome in northeastern Brazil, is widely recognized and traditionally employed in the treatment of pulmonary diseases. Many studies corroborate popular knowledge about the medicinal applications of A. colubrina, which has demonstrated a remarkable variety of pharmacological properties, however, its anti-inflammatory and antioxidant properties are highlighted...
April 18, 2024: Journal of Ethnopharmacology
https://read.qxmd.com/read/38642558/generation-of-human-alveolar-epithelial-type-i-cells-from-pluripotent-stem-cells
#12
JOURNAL ARTICLE
Claire L Burgess, Jessie Huang, Pushpinder S Bawa, Konstantinos-Dionysios Alysandratos, Kasey Minakin, Lauren J Ayers, Michael P Morley, Apoorva Babu, Carlos Villacorta-Martin, Maria Yampolskaya, Anne Hinds, Bibek R Thapa, Feiya Wang, Adeline Matschulat, Pankaj Mehta, Edward E Morrisey, Xaralabos Varelas, Darrell N Kotton
Alveolar epithelial type I cells (AT1s) line the gas exchange barrier of the distal lung and have been historically challenging to isolate or maintain in cell culture. Here, we engineer a human in vitro AT1 model system via directed differentiation of induced pluripotent stem cells (iPSCs). We use primary adult AT1 global transcriptomes to suggest benchmarks and pathways, such as Hippo-LATS-YAP/TAZ signaling, enriched in these cells. Next, we generate iPSC-derived alveolar epithelial type II cells (AT2s) and find that nuclear YAP signaling is sufficient to promote a broad transcriptomic shift from AT2 to AT1 gene programs...
April 15, 2024: Cell Stem Cell
https://read.qxmd.com/read/38637891/treatment-of-covid-19-associated-ards-with-umbilical-cord-derived-mesenchymal-stromal-cells-in-the-stroma-cov-2-multicenter-randomized-double-blind-trial-long-term-safety-respiratory-function-and-quality-of-life
#13
JOURNAL ARTICLE
Alexandre Sitbon, Caroline Hauw-Berlemont, Miryam Mebarki, Nicholas Heming, Julien Mayaux, Jean-Luc Diehl, Alexandre Demoule, Djillali Annane, Clémence Marois, Sophie Demeret, Emmanuel Weiss, Guillaume Voiriot, Muriel Fartoukh, Jean-Michel Constantin, Bruno Mégarbane, Gaëtan Plantefève, Hélène Boucher-Pillet, Guillaume Churlaud, Audrey Cras, Camille Maheux, Chloé Pezzana, Mamadou Hassimiou Diallo, Said Lebbah, Jacques Ropers, Joe-Elie Salem, Christian Straus, Philippe Menasché, Jérôme Larghero, Antoine Monsel
BACKGROUND: The STROMA-CoV-2 study was a French phase 2b, multicenter, double-blind, randomized, placebo-controlled clinical trial that did not identify a significant efficacy of umbilical cord-derived mesenchymal stromal cells in patients with SARS-CoV-2-induced acute respiratory distress syndrome. Safety on day 28 was found to be good. The aim of our extended study was to assess the 6- and 12-month safety of UC-MSCs administration in the STROMA-CoV-2 cohort. METHODS: A detailed multi-domain assessment was conducted at 6 and 12 months following hospital discharge focusing on adverse events, lung computed tomography-scan, pulmonary and muscular functional status, and quality of life in the STROMA-CoV-2 cohort including SARS-CoV-2-related early (< 96 h) mild-to-severe acute respiratory distress syndrome...
April 19, 2024: Stem Cell Research & Therapy
https://read.qxmd.com/read/38637875/pleuroparenchymal-fibroelastosis-as-a-late-complication-of-childhood-cancer-therapy-a-case-series
#14
JOURNAL ARTICLE
Priya H Marathe, Valeria Santibanez, Paul A Meyers, Maria L Padilla, Danielle N Friedman
Pleuroparenchymal fibroelastosis (PPFE) is a rare interstitial pneumonia with distinct clinicopathologic features. It has been associated with exposure to hematopoietic stem cell transplantation (HSCT) and classical alkylating agents. Here, we highlight PPFE as a late complication of childhood cancer therapy by describing the cases of four survivors of childhood cancer with a diagnosis of treatment-related PPFE. All patients received high-dose alkylating agents. PPFE should be considered in the differential diagnosis of restrictive lung disease in patients with history of exposure to alkylating agents or HSCT...
April 18, 2024: Pediatric Blood & Cancer
https://read.qxmd.com/read/38637419/the-ras-oncogene-in-brain-tumors-and-the-involvement-of-let-7-microrna
#15
REVIEW
Samantha Messina
RAS oncogenes are master regulator genes in many cancers. In general, RAS-driven cancers have an oncogenic RAS mutation that promotes disease progression (colon, lung, pancreas). In contrast, brain tumors are not necessarily RAS-driven cancers because RAS mutations are rarely observed. In particular, glioblastomas (the most lethal brain tumor) do not appear to have dominant genetic mutations that are suitable for targeted therapy. Standard treatment for most brain tumors continues to focus on maximal surgical resection, radiotherapy and chemotherapy...
April 18, 2024: Molecular Biology Reports
https://read.qxmd.com/read/38636493/mirnas-mediate-impact-of-smoking-on-dental-pulp-stem-cells-via-p53-pathway
#16
JOURNAL ARTICLE
Leyla Tahrani Hardin, Nabil Abid, David Vang, Xiaoyuan Han, Der Thor, David M Ojcius, Nan Xiao
Cigarette smoke changes the genomic and epigenomic imprint of cells. In this study, we investigated the biological consequences of extended cigarette smoke exposure on dental pulp stem cells (DPSCs) and the potential roles of miRNAs. DPSCs were treated with various doses of cigarette smoke condensate (CSC) for up to six weeks. Cell proliferation, survival, migration, and differentiation were evaluated. Cytokine and miRNA expression were profiled. The results showed that extended exposure to CSC significantly impaired the regenerative capacity of the DPSCs...
April 18, 2024: Toxicological Sciences: An Official Journal of the Society of Toxicology
https://read.qxmd.com/read/38635761/transcriptomics-analysis-identifies-the-decline-in-the-at2-stem-cell-niches-in-aged-human-lungs
#17
JOURNAL ARTICLE
Xue Liu, Xuexi Zhang, Changfu Yao, Jiurong Liang, Paul W Noble, Dianhua Jiang
Aging poses a global public health challenge, which is linked to the rise of age-related lung diseases. The precise understanding of the molecular and genetic changes in the aging lung that elevate the risk of acute and chronic lung diseases remains incomplete. Alveolar type II (AT2) cells are stem cells that maintain epithelial homeostasis and repair the lung after injury. AT2 progenitor function decreases with aging. The maintenance of AT2 function requires niche support from other cell types, but little has been done to characterize alveolar alterations with aging in the AT2 niche...
April 18, 2024: American Journal of Respiratory Cell and Molecular Biology
https://read.qxmd.com/read/38634859/deep-learning-based-optimization-of-field-geometry-for-total-marrow-irradiation-delivered-with-volumetric-modulated-arc-therapy
#18
JOURNAL ARTICLE
Nicola Lambri, Giorgio Longari, Daniele Loiacono, Ricardo Coimbra Brioso, Leonardo Crespi, Carmela Galdieri, Francesca Lobefalo, Giacomo Reggiori, Roberto Rusconi, Stefano Tomatis, Luisa Bellu, Stefania Bramanti, Elena Clerici, Chiara De Philippis, Damiano Dei, Pierina Navarria, Carmelo Carlo-Stella, Ciro Franzese, Marta Scorsetti, Pietro Mancosu
BACKGROUND: Total marrow (lymphoid) irradiation (TMI/TMLI) is a radiotherapy treatment used to selectively target the bone marrow and lymph nodes in conditioning regimens for allogeneic hematopoietic stem cell transplantation. A complex field geometry is needed to cover the large planning target volume (PTV) of TMI/TMLI with volumetric modulated arc therapy (VMAT). Five isocenters and ten overlapping fields are needed for the upper body, while, for patients with large anatomical conformation, two specific isocenters are placed on the arms...
April 18, 2024: Medical Physics
https://read.qxmd.com/read/38627980/loss-of-ovol2-in-triple-negative-breast-cancer-promotes-fatty-acid-oxidation-fueling-stemness-characteristics
#19
JOURNAL ARTICLE
Ruipeng Lu, Jingjing Hong, Tong Fu, Yu Zhu, Ruiqi Tong, Di Ai, Shuai Wang, Qingsong Huang, Ceshi Chen, Zhiming Zhang, Rui Zhang, Huiling Guo, Boan Li
Triple-negative breast cancer (TNBC), the most aggressive subtype of breast cancer, has a poor prognosis and lacks effective treatment strategies. Here, the study discovered that TNBC shows a decreased expression of epithelial transcription factor ovo-like 2 (OVOL2). The loss of OVOL2 promotes fatty acid oxidation (FAO), providing additional energy and NADPH to sustain stemness characteristics, including sphere-forming capacity and tumor initiation. Mechanistically, OVOL2 not only suppressed STAT3 phosphorylation by directly inhibiting JAK transcription but also recruited histone deacetylase 1 (HDAC1) to STAT3, thereby reducing the transcriptional activation of downstream genes carnitine palmitoyltransferase1 (CPT1A and CPT1B)...
April 16, 2024: Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
https://read.qxmd.com/read/38626774/fully-synthetic-tunable-poly-%C3%AE-amino-acids-as-the-base-of-bioinks-curable-by-visible-light
#20
JOURNAL ARTICLE
Anna Golunova, Jana Dvořáková, Nadiia Velychkivska, Beata Strachota, Aneta Dydowiczová, Jiří Trousil, Vladimir Proks
Bioinks play a crucial role in tissue engineering, influencing mechanical and chemical properties of the printed scaffold as well as the behavior of encapsulated cells. Recently, there has been a shift from animal origin materials to their synthetic alternatives. In this context, we present here bioinks based on fully synthetic and biodegradable poly(α,L-amino acids) (PolyAA) as an alternative to animal-based gelatin methacrylate (Gel-Ma) bioinks. Additionally, we first reported the possibility of the visible light photoinitiated incorporation of the bifunctional cell adhesive RGD peptide into the PolyAA hydrogel matrix...
April 16, 2024: Biomedical Materials
keyword
keyword
88552
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.